Industry Insights
The global Transmucosal Drug Delivery Devices market is expected to grow at an anticipated CAGR of 5.3% over the forecast period. Growing usage of transmucosal drug delivery devices both in hospital and residential applications, government efforts to boost medical infrastructure and rising standard of living prompting to increased medical spending are expected to benefit the overall market growth.
The global Transmucosal Drug Delivery Devices market is segmented on the basis of Type and Application. The global Transmucosal Drug Delivery Devices market is segmented based on Type as Buccal Route, Rectal Route, and Nasal Route. Based on Application the global Transmucosal Drug Delivery Devices market is segregated as Hospital and Residential.
The regional outlook on the global Transmucosal Drug Delivery Devices market covers regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Transmucosal Drug Delivery Devices market for each region is further bifurcated for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Landscape
Companies are trying to develop products in line with the current trends and developments. For example, companies have introduced products which can be used in residential applications as well. The global Transmucosal Drug Delivery Devices market is highly competitive in nature with major players including Allergan, Amphastar Pharmaceuticals Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aquestive Therapeutics Inc, Callitas Therapeutics Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, and others. The report covers competitive analysis on the key market share holders. The companies are focused on several expansion and growth strategies to enhance their footprint in the Transmucosal Drug Delivery Devices market. Market players are also involved in value chain integration gain competitive advantage.
Report Scope:
The Transmucosal Drug Delivery Devices market report scope covers the in-depth business analysis considering major market dynamics, forecast parameters, and price trends for the industry growth. The report forecasts market sizing at global, regional and country levels, providing comprehensive outlook of industry trends in each market segments and sub-segments from 2017 to 2024. The market segmentations include,
Transmucosal Drug Delivery Devices Market, By Type
• Buccal Route
• Rectal Route
• Nasal Route
Transmucosal Drug Delivery Devices Market, By Application
• Hospital
• Residential
Transmucosal Drug Delivery Devices Market, By Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
The report scope also includes competitive landscape covering the competitive analysis, strategy analysis and company profiles of the major market players. The companies profiled in the report include Allergan, Amphastar Pharmaceuticals Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aquestive Therapeutics Inc, Callitas Therapeutics Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, and others. Company profiles cover company overview, product landscape, financial overview, and strategy analysis.
Report Highlights
• Global Transmucosal Drug Delivery Devices market sizes from 2017 to 2024
• Market growth projections through 2024 and the resultant market forecast for 2024
• Impact of the market dynamics including market drivers, restraints and opportunities in the market size
• Key industry trends, product trends, and application trends
• Major driving/ leading segmentations, regions and countries in the global Transmucosal Drug Delivery Devices market
• Competitive analysis with comprehensive company profiles of the leading industry players
• In-depth analysis on growth and expansion strategies adopted by market players and their resulting effect on market growth and competition
Report Customizations
The customization research services cover the additional custom report features such as additional regional and country level analysis as per the client requirements.
Table of Contents
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5. Transmucosal Drug Delivery Devices Market, By Type
5.1 Introduction
5.2 Buccal Route
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Rectal Route
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Nasal Route
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Transmucosal Drug Delivery Devices Market, By Application
6.1 Introduction
6.2 Hospital
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Residential
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Transmucosal Drug Delivery Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Transmucosal Drug Delivery Devices, By Type
7.2.2 North America Transmucosal Drug Delivery Devices, By Application
7.3 Europe
7.3.1 Europe Transmucosal Drug Delivery Devices, By Type
7.3.2 Europe Transmucosal Drug Delivery Devices, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Transmucosal Drug Delivery Devices, By Type
7.4.2 Asia-Pacific Transmucosal Drug Delivery Devices, By Application
7.5 Rest of the World
7.5.1 Rest of the World Transmucosal Drug Delivery Devices, By Type
7.5.2 Rest of the World Transmucosal Drug Delivery Devices, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Allergan
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Amphastar Pharmaceuticals Inc
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 ARS Pharmaceuticals
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Combinent BioMedical Systems Inc
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Aquestive Therapeutics Inc
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Callitas Therapeutics Inc
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Aegis Therapeutics LLC
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Bespak Europe Ltd
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach
Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.
Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis
Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price
Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
